| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/29/2004 | US6756233 Method for measuring free ligands in biological fluids, and assay kits for measuring same |
| 06/29/2004 | US6756230 Measuring concentration of preferential particles in sample; measure sample, measure control, compare and determine the amount of preferential particles in sample |
| 06/29/2004 | US6756224 Device for receiving a chip shaped carrier and process for assembling a plurality of such devices |
| 06/29/2004 | US6756219 Human secretory type phospholipase a2 |
| 06/29/2004 | US6756217 Glass composite materials containing alkoxosilane derivative having alterable charge, hydrophobic and hydrophilic groups |
| 06/29/2004 | US6756213 Nucleic acid encoding retinoic acid receptor |
| 06/29/2004 | US6756212 Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof |
| 06/29/2004 | US6756211 Neutropohil inhibitors |
| 06/29/2004 | US6756210 Detecting pre-eclampsia, and pregnancy-induced hypertension by way of abnormal regulation of cytochrome p450 metabolism; enzyme inhibitors; oxidoreductases; epoxide hydrolases |
| 06/29/2004 | US6756207 For rapidly determining the distribution, environment, or activity of fluorescently labeled reporter molecules in cells for the purpose of screening large numbers of compounds for those that specifically affect particular biological functions |
| 06/29/2004 | US6756201 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 06/29/2004 | US6756198 Nucleotide sequences for use in the treatment of and prevention of viral infections |
| 06/29/2004 | US6756197 Collagenase 3 as a prognostic marker for rheumatoid arthritis |
| 06/29/2004 | US6756055 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells |
| 06/29/2004 | US6756043 For diagnosing taeniasis (pork tapeworm) |
| 06/29/2004 | US6756036 Methods for treating cancer using PSCA antibodies and fragments thereof |
| 06/29/2004 | US6756026 Catalytic end to end connecting of single wall nanotubes using gaseous carbon |
| 06/29/2004 | US6756025 Injecting particle suspension containing attached catalysts into evaporation zone producing nanoparticle stream then introducing carbonaceous feedstock gas |
| 06/29/2004 | US6756015 Apparatus for treating objects |
| 06/29/2004 | US6756014 Chemical detector; for use in the detection of preferential particles in solution |
| 06/29/2004 | US6755802 Whole blood sampling device |
| 06/29/2004 | US6755085 Golf ball testing apparatus |
| 06/29/2004 | CA2403989C Biotin-peg-substrate for a lipase assay |
| 06/29/2004 | CA2346055C Method and device for predicting physiological values |
| 06/29/2004 | CA2334802C Device for the testing of fluid samples and process for making the device |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2276570C Method of pcr testing of pooled blood samples |
| 06/29/2004 | CA2242347C A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
| 06/29/2004 | CA2180128C Non-invasive non-spectrophotometric infrared measurement of blood analyte concentrations |
| 06/29/2004 | CA2175910C Glucose calibrator and control material for test strips |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/27/2004 | CA2454032A1 Method for calculating physical properties, physical properties calculating apparatus, and computer program product |
| 06/27/2004 | CA2451588A1 Protein having active sulfate transporter activity and method for detecting canceration of tissue |
| 06/24/2004 | WO2004053929A2 Semiconductor nanocrystal heterostructures |
| 06/24/2004 | WO2004053920A2 Humidified imaging with an environmental scanning electron microscope |
| 06/24/2004 | WO2004053769A2 A browsable database for biological use |
| 06/24/2004 | WO2004053500A1 Method of quantifying small-sized low density lipoprotein |
| 06/24/2004 | WO2004053499A1 Fluorescent indicator using fret |
| 06/24/2004 | WO2004053498A1 Method of analyzing c-terminal amino acid sequence of peptide |
| 06/24/2004 | WO2004053497A2 Method for predicting the response to her2-directed therapy |
| 06/24/2004 | WO2004053496A1 Use of substances binding to hat for the diagnosis and treatment of squamous carcinomas of the lung |
| 06/24/2004 | WO2004053495A1 Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) |
| 06/24/2004 | WO2004053494A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) |
| 06/24/2004 | WO2004053493A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) |
| 06/24/2004 | WO2004053492A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3) |
| 06/24/2004 | WO2004053491A1 Biosensor with rf signal transmission |
| 06/24/2004 | WO2004053490A1 Particles |
| 06/24/2004 | WO2004053489A1 Immunoreaction measurement method |
| 06/24/2004 | WO2004053488A1 Materials and methods relating to herpes simplex virus icp34.5 encoded protein complexes |
| 06/24/2004 | WO2004053487A1 METHOD OF DIAGNOSIS,TREATMENT AND USEFUL AGENTS FOR CONDITIONS CHARACTERISED BY MODULATION IN THE LEVEL OF ACTIVIN βC |
| 06/24/2004 | WO2004053484A2 Method for screening for agents preventing aggregation of potentially amyloidogenic proteins |
| 06/24/2004 | WO2004053483A2 Multi-analyte reference solutions |
| 06/24/2004 | WO2004053481A2 Method and installation for determining the end of the cross-linking of a compound comprising reactive synthetic materials |
| 06/24/2004 | WO2004053474A2 Gas detector for indicating failure of equipment or for monitoring ambient air |
| 06/24/2004 | WO2004053469A1 Solid-state light source photolytic nitrogen dioxide converter |
| 06/24/2004 | WO2004053468A1 Image analysis of heterogeneous mixtures |
| 06/24/2004 | WO2004053467A2 Optical sensor for determining the concentrations of dyes and/or particles in liquid or gaseous media and method for operating the same |
| 06/24/2004 | WO2004053460A2 Carrier-ligand fusions and uses thereof |
| 06/24/2004 | WO2004053459A2 Compounds and mehtods of use thereof for assaying lysophospholipase d activity |
| 06/24/2004 | WO2004053454A2 Methods for detecting invasion of a cell |
| 06/24/2004 | WO2004053452A2 Assays relating to toll-like receptor activity |
| 06/24/2004 | WO2004053163A1 Method for identifying, analyzing and/or cloning nucleic acid isoforms |
| 06/24/2004 | WO2004053162A1 Method of distinguishing drug-resistance of hepatitis b virus |
| 06/24/2004 | WO2004053154A1 Magnetism based nucleic acid amplification |
| 06/24/2004 | WO2004053148A1 Method for the detection of pathogenic gram positive bacteria from the genera staphylococcus, enterococcus and streptococcus |
| 06/24/2004 | WO2004053144A2 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 06/24/2004 | WO2004053142A2 P53-associated parkin-like cytoplasmic protein, and related compositions and methods |
| 06/24/2004 | WO2004053128A1 Mutations in gaba-b receptor 1 associated with epilepsy |
| 06/24/2004 | WO2004053124A1 Method of screening remedy or preventive for diabetes |
| 06/24/2004 | WO2004053115A1 Magnetism based rapid cell separation |
| 06/24/2004 | WO2004053097A2 Chemopreventive and therapeutic aspects of polyphenolic compositions and assays |
| 06/24/2004 | WO2004053071A2 Method for discovering neurogenic agents |
| 06/24/2004 | WO2004053066A2 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 06/24/2004 | WO2004053063A2 Molecular determinants of myeloma bone disease and uses thereof |
| 06/24/2004 | WO2004053061A2 Methods of therapy and diagnosis using targeting of cells that express lax |
| 06/24/2004 | WO2004053057A2 Gene expression systems and recombinant cell lines |
| 06/24/2004 | WO2004052934A1 Monitor protein for measuring processing of protein |
| 06/24/2004 | WO2004052920A2 Conversion of apoptotic proteins |
| 06/24/2004 | WO2004052918A2 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides |
| 06/24/2004 | WO2004052913A1 A digoxin labelled glycan probe, its use and methods for its production |
| 06/24/2004 | WO2004052528A1 Capacitive detection of bound molecules |
| 06/24/2004 | WO2004052389A2 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004052359A1 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 06/24/2004 | WO2004052303A2 A method for creating nuclear receptor activity modulating pharmaceuticals |
| 06/24/2004 | WO2004052302A2 A method for creating specific, high affinity nuclear receptor pharmaceuticals |
| 06/24/2004 | WO2004052290A2 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 06/24/2004 | WO2004052197A1 Solid bio-material for a sensor that detects bio-electric signals through the use of the characteristics and functions of bio-epidermal tissues and epidermal tissues of living organisms and the methods for producing the same |
| 06/24/2004 | WO2004052184A2 Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| 06/24/2004 | WO2004052175A2 Methods for rapid identification of pathogens in humans and animals |
| 06/24/2004 | WO2004041862A3 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 06/24/2004 | WO2004040285A3 Preconditioning of a substrate in a continuous process for manufacture of electrochemical sensors |
| 06/24/2004 | WO2004038421A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) |
| 06/24/2004 | WO2004037206A3 Methods for diagnosing and treating pre-term labor |
| 06/24/2004 | WO2004036212A3 Method for the determination of the endotoxin content in liquids |
| 06/24/2004 | WO2004034053A3 Sensor strip having a capillary flow channel with a flow terminating interface |
| 06/24/2004 | WO2004027426A3 Method for using a blank matrix in a continuous format high throughput screening process |
| 06/24/2004 | WO2004027386A3 Thermal analysis of energetic materials |
| 06/24/2004 | WO2004027382A3 Sensor assemblies and methods of securing elongated members within such assemblies |
| 06/24/2004 | WO2004025672A3 Composite electrode for electrochemical cod measurement |